الصفحة الرئيسية>>Analytical Standards>> Certified Reference Materials>>Deschloroketamine (hydrochloride)

Deschloroketamine (hydrochloride) (Synonyms: 2'-oxo-PCM, deschloro-N-methyl-Ketamine, O-PCM)

رقم الكتالوجGC18643

A Certified Reference Material

Products are for research use only. Not for human use. We do not sell to patients.

Deschloroketamine (hydrochloride) التركيب الكيميائي

Cas No.: 4631-27-0

الحجم السعر المخزون الكميّة
1mg
148٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 1 publications

Description Chemical Properties Product Documents Related Products
Deschloroketamine (hydrochloride) is an analytical reference material that is structurally categorized as an amphetamine. It is classified as a dissociative anesthetic that antagonizes NMDA receptors and has been abused recreationally. The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research purposes. This product is a qualified Reference Material (RM) that has been manufactured and tested to meet ISO17025 and Guide 34 guidelines. These materials are tested using validated analytical methods on qualified instrumentation to ensure traceability of measurements. All traceable RMs may be distinguished by their CofAs and can be downloaded below using the batch number located on the product label. For a representative CofA please contact our technical support.

مراجعات

Review for Deschloroketamine (hydrochloride)

Average Rating: 5 ★★★★★ (Based on Reviews and 21 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Deschloroketamine (hydrochloride)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.